The litigation targets Zoetis and its leadership, questioning whether the company engaged in unlawful business practices that misled shareholders. The scrutiny follows a tumultuous May 7, 2026, earnings report where the company revealed stagnant net income of $601 million and lowered its annual profit guidance to between $6.85 and $7 per share.

During that session, CEO Kristin Peck attributed the lackluster performance to a difficult operating environment, noting that pet owners were becoming increasingly price-sensitive, which led to fewer veterinary visits. The market reacted sharply to the revised projections, sending Zoetis shares tumbling $23.91—a 21.5% drop—to close at $87.31. Investors looking to participate in the class action or seeking further information regarding the complaint are directed to contact Danielle Peyton at Pomerantz LLP.